HB NEW YORK. Reserves of almost a billion dollars because of the dispute over the withdrawn painkiller Vioxx from the strain on the balance sheet of the U.S. pharmaceutical giant Merck & Co. In addition, the company expects in the third quarter, less than one. The Group reported on Friday for the past quarter of a profit slump of nearly 90 percent to 372 million dollars.
Also completed a year ago’s $ 41 billion takeover of rival Schering-Plough pulled still write after sich.Abgesehen of the many special items the company earned 85 cents per share, and had slightly more than expected industry experts.
Thanks to the Schering-Plough acquisition doubled the sales of the Group nearly $ 11,120,000,000. The increase was still just short of analysts’ forecasts.